Sumoylation of Rta of Epstein-Barr virus is preferentially enhanced by PIASxβ

Virus Research

Volumn 119, Issue 2, 2006, Pages 163-170

  Liu, Shih Tung ^a   Wang, Wen Hung ^a   Hong, Yi Ren ^b   Chuang, Jian Ying ^a   Lu, Pei Jung ^c   Chang, Li Kwan ^b  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^c KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

EBV; PIASx ; PIASx ; Rta

Indexed keywords

PROTEIN PIASXBETA; PROTEIN RTA; PROTEIN UBC9; SUMO 1 PROTEIN; SUMO PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ARTICLE; CONTROLLED STUDY; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; IMMUNOPRECIPITATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; TWO HYBRID SYSTEM;

CELL NUCLEUS; GENE EXPRESSION REGULATION; GENES, REPORTER; HERPESVIRUS 4, HUMAN; IMMEDIATE-EARLY PROTEINS; IMMUNOPRECIPITATION; LUCIFERASES; MICROSCOPY, CONFOCAL; MICROSCOPY, FLUORESCENCE; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; PROTEIN INHIBITORS OF ACTIVATED STAT; SUMO-1 PROTEIN; TRANS-ACTIVATION (GENETICS); TRANS-ACTIVATORS; TWO-HYBRID SYSTEM TECHNIQUES; VIRAL PROTEINS;

HUMAN HERPESVIRUS 4;

EID: 33646807840     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virusres.2006.01.004     Document Type: Article

References (41)

1. Adamson A.L., and Kenney S. Epstein-barr virus immediate-early protein BZLF1 is SUMO-1 modified and disrupts promyelocytic leukemia bodies. J. Virol. 75 (2001) 2388-2399
2. Biggin M., Bodescot M., Perricaudet M., and Farrell P. Epstein-Barr virus gene expression in P3HRl-superinfected Raji cells. J. Virol. 61 (1987) 3120-3132
3. Chang L.K., and Liu S.T. Activation of the BRLF1 promoter and lytic cycle of Epstein-Barr virus by histone acetylation. Nucleic Acids Res. 28 (2000) 3918-3925
4. Chang L.K., Chung J.Y., Hong Y.R., Ichimura T., Nakao M., and Liu S.T. Activation of Sp1-mediated transcription by Rta of Epstein-Barr virus via an interaction with MCAF1. Nucleic Acids Res. 33 (2005) 6528-6539
5. Chang P.J., Chang Y.S., and Liu S.T. Role of Rta in the translation of bicistronic BZLF1 of Epstein-Barr virus. J. Virol. 72 (1998) 5128-5136
6. Chang L.K., Lee Y.H., Cheng T.S., Hong Y.R., Lu P.J., Wang J.J., Wang W.H., Kuo C.W., Li S.S., and Liu S.T. Post-translational modification of Rta of Epstein-Barr virus by SUMO-1. J. Biol. Chem. 279 (2004) 38803-38812
7. Chang Y., Lee H.H., Chang S.S., Hsu T.Y., Wang P.W., Chang Y.S., Takada K., and Tsai C.H. Induction of Epstein-Barr virus latent membrane protein 1 by a lytic transactivator Rta. J. Virol. 78 (2004) 13028-13036
8. Chung C.D., Liao J., Liu B., Rao X., Jay P., Berta P., and Shuai K. Specific inhibition of Stat3 signal transduction by PIAS3. Science 278 (1997) 1803-1805
9. Desterro J.M., Thomson J., and Hay R.T. Ubch9 conjugates SUMO but not ubiquitin. FEBS Lett. 417 (1997) 297-300
10. Flemington E.K., Goldfeld A.E., and Speck S.H. Efficient transcription of the Epstein-Barr virus immediate-early BZLF1 and BRLF1 genes requires protein synthesis. J. Virol. 65 (1991) 7073-7077
11. Gong L., Kamitani T., Fujise K., Caskey L.S., and Yeh E.T. Preferential interaction of sentrin with a ubiquitin-conjugating enzyme, Ubc9. J. Biol. Chem. 272 (1997) 28198-28201
12. Jang M.S., Ryu S.W., and Kim E. Modification of Daxx by small ubiquitin-related modifier-1. Biochem. Biophys. Res. Commun. 295 (2002) 495-500
13. Johnson E.S., and Blobel G. Ubc9p is the conjugating enzyme for the ubiquitin-like protein Smt3p. J. Biol. Chem. 272 (1997) 26799-26802
14. Johnson E.S., and Gupta A.A. An E3-like factor that promotes SUMO conjugation to the yeast septins. Cell 106 (2001) 735-744
15. Kim J., Sharma S., Li Y., Cobos E., Palvimo J.J., and Williams S.C. Repression and coactivation of CCAAT/enhancer-binding protein epsilon by sumoylation and protein inhibitor of activated STATx proteins. J. Biol. Chem. 280 (2005) 12246-12254
16. Kotaja N., Karvonen U., Janne O.A., and Palvimo J.J. PIAS proteins modulate transcription factors by functioning as SUMO-1 ligases. Mol. Cell. Biol. 22 (2002) 5222-5234
17. Lee P.S., Chang C., Liu D., and Derynck R. Sumoylation of Smad4, the common Smad mediator of transforming growth factor-beta family signaling. J. Biol. Chem. 278 (2003) 27853-27863
18. Lee T.H., Chuang L.Y., and Hung W.C. Induction of p21WAF1 expression via Sp1-binding sites by tamoxifen in estrogen receptor-negative lung cancer cells. Oncogene 19 (2000) 3766-3773
19. Liu B., Liao J., Rao X., Kushner S.A., Chung C.D., Chang D.D., and Shuai K. Inhibition of Stat1-mediated gene activation by PIAS1. Proc. Natl. Acad. Sci. USA 95 (1998) 10626-10631
20. Miyauchi Y., Yogosawa S., Honda R., Nishida T., and Yasuda H. Sumoylation of Mdm2 by protein inhibitor of activated STAT (PIAS) and RanBP2 enzymes. J. Biol. Chem. 277 (2002) 50131-50136
21. Moilanen A.M., Karvonen U., Poukka H., Yan W., Toppari J., Janne O.A., and Palvimo J.J. A testis-specific androgen receptor coregulator that belongs to a novel family of nuclear proteins. J. Biol. Chem. 274 (1999) 3700-3704
22. Muller S., Hoege C., Pyrowolakis G., and Jentsch S. SUMO, ubiquitin's mysterious cousin. Nat. Rev. Mol. Cell. Biol. 2 (2001) 202-210
23. Nishida T., and Yasuda H. PIAS1 and PIASxalpha function as SUMO-E3 ligases toward androgen receptor and repress androgen receptor-dependent transcription. J. Biol. Chem. 277 (2002) 41311-41317
24. Pichler A., Gast A., Seeler J.S., Dejean A., and Melchior R. The nucleoporin RanBP2 has SUMO1 E3 ligase activity. Cell 108 (2002) 109-120
25. Rodriguez M.S., Dargemont C., and Hay R.T. SUMO-1 conjugation in vivo requires both a consensus modification motif and nuclear targeting. J. Biol. Chem. 276 (2001) 12654-12659
26. Rosas-Acosta G., Langereis M.A., Deyrieux A., and Wilson V.G. Proteins of the PIAS family enhance the sumoylation of the papillomavirus E1 protein. Virology 331 (2005) 190-203
27. Sachdev S., Bruhn L., Sieber H., Pichler A., Melchior E., and Grosschedl R. PIASy, a nuclear matrix-associated SUMO E3 ligase, represses LEF1 activity by sequestration into nuclear bodies. Genes Dev. 15 (2001) 3088-3103
28. Sambrook J., Fritsch E.F., and Maniatis T. Molecular Cloning: A Laboratory Manual (1989), Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
29. Sampson D.A., Wang M., and Matunis M.J. The small ubiquitin-like modifier-1 (SUMO-1) consensus sequence mediates Ubc9 binding and is essential for SUMO-1 modification. J. Biol. Chem. 276 (2001) 21664-21669
30. Sapetschnig A., Rischitor G., Braun H., Doll A., Schergaut M., Melchior F., and Suske G. Transcription factor Sp3 is silenced through SUMO modification by PIAS1. EMBO J 21 (2002) 5206-5215
31. Schmidt D., and Muller S. Members of the PIAS family act as SUMO ligases for c-Jun and p53 and repress p53 activity. Proc. Natl. Acad. Sci. USA 99 (2002) 2872-2877
32. Schmidt D., and Muller S. PIAS/SUMO: new partners in transcriptional regulation. Cell. Mol. Life Sci. 60 (2003) 2561-2574
33. Schwarz S.E., Matuschewski K., Liakopoulos D., Scheffner M., and Jentsch S. The ubiquitin-like proteins SMT3 and SUMO-1 are conjugated by the UBC9 E2 enzyme. Proc. Natl. Acad. Sci. USA 95 (1998) 560-564
34. Shuai K., and Liu B. Regulation of gene-activation pathways by PIAS proteins in the immune system. Nat. Rev. Immunol. 5 (2005) 593-605
35. Subramanian L., Benson M.D., and Iniguez-Lluhi J.A. A synergy control motif within the attenuator domain of CCAAT/enhancer-binding protein alpha inhibits transcriptional synergy through its PIASy-enhanced modification by SUMO-1 or SUMO-3. J. Biol. Chem. 278 (2003) 9134-9141
36. Swenson J.J., Mauser A.E., Kaufmann W.K., and Kenney S.C. The Epstein-Barr virus protein BRLF1 activates S phase entry through E2F1 induction. J. Virol. 73 (1999) 6540-6550
37. Takada K., and Ono Y. Synchronous and sequential activation of latently infected Epstein-Barr virus genomes. J. Virol. 63 (1989) 445-449
38. Takahashi H., Hatakeyama S., Saitoh H., and Nakayama K.I. Noncovalent SUMO-1 binding activity of thymine DNA glycosylase (TDG) is required for its SUMO-1 modification and colocalization with the promyelocytic leukemia protein. J. Biol. Chem. 280 (2005) 5611-5621
39. Takahashi K., Taira T., Niki T., Seino C., Iguchi-Ariga S.M., and Ariga H. DJ-1 positively regulates the androgen receptor by impairing the binding of PIASx alpha to the receptor. J. Biol. Chem. 276 (2001) 37556-37563
40. Valdez B.C., Henning D., Perlaky L., Busch R.K., and Busch H. Cloning and characterization of Gu/RH-II binding protein. Biochem. Biophys. Res. Commun. 234 (1997) 335-340
41. Wu L., Wu H., Ma L., Sangiorgi E., Wu N., Bell J.R., Lyons G.E., and Maxson R. Miz1, a novel zinc finger transcription factor that interacts with Msx2 and enhances its affinity for DNA. Mech. Dev. 65 (1997) 3-17